14) Transformational Medical Technologies Initiative
Abstract
Development of Platform Technologies: Mature the components necessary to develop an integrated capability from pathogen identification and characterization to countermeasure delivery. Off-the-shelf technologies will be identified, evaluated, and where applicable, refined to demonstrate the ability to provide drug development capabilities. Drug evaluation needs will continue to advance the maturity of animal models specific for each BW agent therapeutic.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2011
- Source ID
- b2122886b334ed351313519aa60f2004